Article Details

Design Therapeutics Secures $125 Million in Series B Financing to Advance Pipeline of Genomic ...

Retrieved on: 2021-01-27 13:41:15

Tags for this article:

Click the tags to see associated articles and topics

Design Therapeutics Secures $125 Million in Series B Financing to Advance Pipeline of Genomic .... View article details on hiswai:

Excerpt

Design Therapeutics, a biotechnology company developing a platform of gene targeted chimera (GeneTAC™) small molecules for the treatment of ...

Article found on: www.galvnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo